INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,000 | 0.0% | 130 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -97.0% | 130 | -96.8% | 0.00% | -100.0% |
| Q4 2020 | $134,000 | +3.1% | 4,030 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $130,000 | +51.2% | 4,030 | +29.6% | 0.01% | +40.0% |
| Q2 2020 | $86,000 | +72.0% | 3,110 | -1.3% | 0.01% | +66.7% |
| Q1 2020 | $50,000 | -33.3% | 3,150 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $75,000 | +33.9% | 3,150 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $56,000 | -5.1% | 3,150 | +36.4% | 0.00% | 0.0% |
| Q2 2019 | $59,000 | -11.9% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $67,000 | -50.4% | 2,310 | -65.4% | 0.00% | -50.0% |
| Q3 2018 | $135,000 | -23.7% | 6,670 | -10.8% | 0.00% | -20.0% |
| Q2 2018 | $177,000 | +6.6% | 7,480 | +1.2% | 0.01% | 0.0% |
| Q1 2018 | $166,000 | -84.8% | 7,390 | -86.5% | 0.01% | -87.5% |
| Q2 2014 | $1,091,000 | +0.2% | 54,580 | -4.6% | 0.04% | -4.8% |
| Q1 2014 | $1,089,000 | – | 57,210 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |